Replies to post #91140 on Cytodyn Inc (CYDY)

[Chasing Wealth]

The stock is not optionable as well, so if somebody wants a position in the company then they need to buy a share. If CYDY gets FDA approval, investors and institutions will want a position. Uplisting would be in new investors as well

[HFM2]

I hear you . . . loud and clear. Not doubting your fundamental assumptions at all. I'm simply pointing out that in this very special case what is "reasonable" may not be the end game. It is at least possible (if not probable) that once the drug is seen to be as comprehensive as we think, the MOMO and then FOMO will propel this stock far into the land of the apparently 'unreasonable' valuation. There will be many who will think it cheap, nay, 'undervalued' at $100/share no matter what the MC is! How many trials are starting this year? NP said 10. Sequential significant sources of good news may in this case have a multiplier effect that simply cannot be estimated. Just IMHO. If this were some other random company about to release news about their latest product, say, a new robotic vacuum cleaner, I would be squarely in your camp. The environment into which this company will be releasing news is a powder keg. We already know governments and billionaires are ready to step in . . . and that is just for one indication.

As with all things, Father Time will reveal the truth. I may be wrong . . .